Category: New products
-
Trial to Test Drug Combination for Hospital Infections
A clinical trial scheduled for early 2017 plans to assess the activity of two drugs to treat antibiotic-resistant infections often found in health care facilities.
-
3-D Printing Creates Heart-on-Chip with Sensors
Biomedical engineers at Harvard University developed a programmable and automated process for creating miniature organs on chips with integrated sensors using 3-D printing.
-
Virtual Reality Game in Development for Vision Disorder
An engineering lab at New Jersey Institute of Technology is creating a virtual reality therapy game to treat children with binocular vision dysfunction.
-
Mobile Multichannel Biomarker Detector Designed
An engineering lab designed a portable testing device connected to a smartphone that can analyze multiple specimen samples for a leading cancer biomarker.
-
Commercial Genome Service Launches Based on Open Data
A start-up software company is offering genetic analysis services for research and precision medicine that comply with open standards and access Google’s genomic data sets.
-
Trial Testing Retina Cell Implants for Glaucoma
A new clinical trial is testing implants to treat glaucoma made of genetically engineered retina cells that release hormones promoting optic nerve growth.
-
Sweat Sensor Devised for Blood Glucose Measurement
A bioengineering lab at University of Texas in Dallas developed a miniature biosensor device that measures blood glucose levels from a person’s perspiration.
-
Therapeutic Food-Triggered Gut Microbes in Development
A biologist at Rice University in Houston is developing synthetic intestinal microbe circuits that respond to food to release therapeutic proteins.
-
Worms-On-A-Chip Drug Screening System Designed
A system using live roundworms on a microfluidics chip and high-speed image analysis can quickly and simultaneously screen nearly 100 drug compounds.
-
Trial Shows Ovarian Cancer Drug Safety, Therapy Potential
A clinical trial shows an experimental therapy addressing a common cancer-causing mutation is safe, with early indications of its efficacy against ovarian cancer.